2. Search Result
Search Result
Results for "

decapeptide

" in MedChemExpress (MCE) Product Catalog:

33

Inhibitors & Agonists

4

Biochemical Assay Reagents

27

Peptides

2

Natural
Products

3

Isotope-Labeled Compounds

4

Oligonucleotides

Cat. No. Product Name Target Research Areas Chemical Structure
  • HY-A0190
    Caerulein
    Maximum Cited Publications
    132 Publications Verification

    Ceruletide; Cerulein; FI-6934

    		 Cholecystokinin Receptor Cardiovascular Disease Metabolic Disease
    Caerulein is a decapeptide and a potent cholecystokinin receptor agonist. Caerulein is a safe and effective cholecystokinetic agent with a direct spasmogenic effect on the gallbladder muscle and bile ducts .
    Caerulein
  • HY-16168A
    Degarelix
    10+ Cited Publications

    FE 200486 free base

    		 GnRH Receptor Apoptosis Endocrinology Cancer
    Degarelix acetate (FE 200486) is a decapeptide that shows high affinity/selectivity to human gonadotropin-releasing hormone (GnRH) receptor (IC50 = 3 nM). Degarelix acetate Degarelix acetate (FE 200486) is used for the research of prostate cancer .
    Degarelix
  • HY-13673A
    Goserelin acetate
    1 Publications Verification

    ICI-118630 acetate

    		 GnRH Receptor Apoptosis Endocrinology Cancer
    Goserelin acetate (ICI-118630 acetate), a decapeptide analogue of gonadotropin-releasing hormone (GnRH/LHRH), functions as a GnRH agonist. Goserelin acetate can be used for the research of breast cancer, epithelial ovarian cancer and prostate cancer .
    Goserelin acetate
  • HY-P1032
    Angiotensin I (human, mouse, rat)
    3 Publications Verification

    		 Endogenous Metabolite Angiotensin-converting Enzyme (ACE) Cardiovascular Disease
    Angiotensin I is a decapeptide hormone. Angiotensin I is the precursor of Angiotensin II (HY-13948). Angiotensin I can be used in the study of cardiovascular diseases such as hypertension and vasospasm .
    Angiotensin I (human, mouse, rat)
  • HY-100731
    Cyclosporin
    2 Publications Verification

    		 Cyclophilin Inflammation/Immunology Cancer
    Cyclosporin is a cyclic decapeptide that could be isolated form the soil fungi Tolypocladium inflatum. Cyclosporin is an immunosuppressant thought to bind to cyclophilin in T-lymphocytes .
    Cyclosporin
  • HY-P1116
    PBP10
    1 Publications Verification

    		 Bacterial Reactive Oxygen Species (ROS) Interleukin Related Infection Inflammation/Immunology
    PBP10 is a decapeptide. PBP10 selectively binds to lipoteichoic acid (LTA), lipopolysaccharide (LPS) and phosphatidylinositol-4,5-bisphosphate (PIP2). PBP10 penetrates cell membranes and possesses bactericidal, anti-inflammatory, cell motility-inhibiting and actin assembly-regulating activities. PBP10 is applicable to relevant research on bacterial infections, microbe-induced inflammation, skin and soft tissue infections, as well as sepsis .
    PBP10
  • HY-P0243
    Luteinizing Hormone Releasing Hormone (LH-RH), salmon

    Salmon GnRH; Salmon gonadotropin-releasing hormone; sGnRH

    		 GnRH Receptor Metabolic Disease
    Luteinizing Hormone Releasing Hormone (LH-RH), salmon (Salmon GnRH) is the hypophysiotropic decapeptide synthesized in the hypothalamus that plays a crucial role in the control of reproductive functions.
    Luteinizing Hormone Releasing Hormone (LH-RH), salmon
  • HY-P0096
    Decapeptide-12

    		Tyrosinase Sirtuin Inflammation/Immunology Endocrinology
    Decapeptide-12, a small oligopeptide, is a tyrosinase inhibitor that interacts with C-terminal residue of tyrosinase (Kd: 61.1 μM). Decapeptide-12 is a competitive inhibitor of mushroom tyrosinase (IC50: 40 μM). Decapeptide-12 also increases transcription of SIRT. Decapeptide-12 reduces melanin content in melanocytes. Decapeptide-12 is used for the research of melanogenesis, senescence, inflammation .
    Decapeptide-12
  • HY-106359A
    Delmitide acetate

    RDP-58 acetate

    		 TNF Receptor IFNAR Reactive Oxygen Species (ROS) Cancer
    Delmitide (RDP58) acetate is an orally active d-isomer decapeptide with potent anti-inflammatory activity. Delmitide acetate inhibits production of TNF-α, IFN-γ, and interleukin (IL)-12, and up-regulates heme oxygenase 1 activity. Delmitide acetate can be used for the research of ulcerative colitis .
    Delmitide acetate
  • HY-13673
    Goserelin

    ICI 118630

    		 GnRH Receptor Apoptosis Endocrinology Cancer
    Goserelin (ICI 118630), a decapeptide analogue of gonadotropin-releasing hormone (GnRH/LHRH), functions as a GnRH agonist. Goserelin can be used for the research of breast cancer, epithelial ovarian cancer and prostate cancer .
    Goserelin
  • HY-P1116A
    PBP10 TFA
    1 Publications Verification

    		 Bacterial Infection Inflammation/Immunology
    PBP10 TFA is a decapeptide. PBP10 TFA selectively binds to lipoteichoic acid (LTA), lipopolysaccharide (LPS) and phosphatidylinositol-4,5-bisphosphate (PIP2). PBP10 TFA penetrates cell membranes and possesses bactericidal, anti-inflammatory, cell motility-inhibiting and actin assembly-regulating activities. PBP10 TFA is applicable to relevant research on bacterial infections, microbe-induced inflammation, skin and soft tissue infections, as well as sepsis .
    PBP10 TFA
  • HY-106359
    Delmitide

    RDP-58

    		 TNF Receptor IFNAR Reactive Oxygen Species (ROS) Infection Inflammation/Immunology Cancer
    Delmitide (RDP58) is an orally active d-isomer decapeptide with potent anti-inflammatory activity. Delmitide inhibits production of TNF-α, IFN-γ, and interleukin (IL)-12, and up-regulates heme oxygenase 1 activity. Delmitide can be used for the research of ulcerative colitis .
    Delmitide
  • HY-P3092
    Phyllomedusin

    		Neurokinin Receptor Neurological Disease
    Phyllomedusin, an tachykinin decapeptide, is a NK1 receptor agonist. Phyllomedusin has vasodilating activity and provokes the contraction of the pylorus .
    Phyllomedusin
  • HY-16168
    Degarelix acetate
    10+ Cited Publications

    FE 200486

    		 GnRH Receptor Cancer
    Degarelix acetate (FE 200486) is a decapeptide that shows high affinity/selectivity to human gonadotropin-releasing hormone (GnRH) receptor (IC50 = 3 nM). Degarelix acetate (FE 200486) is used for the research of prostate cancer .
    Degarelix acetate
  • HY-P1755A
    p53 (17-26) acetate

    		MDM-2/p53 Cancer
    p53 (17-26) acetate is a peptide derived from the P53 MDM2 binding domain, with a Kd of 50 nM for MDM2. p53 (17-26) acetate causes cell lysis by damaging cancer cells and nuclear membranes, and induces cancer cell necrosis. p53 (17-26) acetate exhibits antitumor activity and is applicable to research related to pancreatic cancer .
    p53 (17-26) acetate
  • HY-13673S2
    Goserelin-d7 TFA

    ICI 118630-d7 TFA

    		 Isotope-Labeled Compounds Apoptosis GnRH Receptor Endocrinology Cancer
    Goserelin-d7 (TFA) is deuterium labeled Goserelin. Goserelin (ICI 118630), a decapeptide analogue of gonadotropin-releasing hormone (GnRH/LHRH), functions as a GnRH agonist. Goserelin can be used for the research of breast cancer, epithelial ovarian cancer and prostate cancer .
    Goserelin-d7 TFA
  • HY-P1800
    Caerulein, desulfated

    		Cholecystokinin Receptor Metabolic Disease
    Caerulein, desulfated is the desulfurated form of Caerulein. Caerulein is a decapeptide having the same five carboxyl-terminal amino acids as gastrin and cholecystokinin (CCK) .
    Caerulein, desulfated
  • HY-158722
    Caerulein acetate

    		Cholecystokinin Receptor Cardiovascular Disease Metabolic Disease Endocrinology
    Caerulein acetate is a decapeptide and a potent cholecystokinin receptor agonist. Ceruletide acetate is a safe and effective cholecystokinetic agent with a direct spasmogenic effect on the gallbladder muscle and bile ducts .
    Caerulein acetate
  • HY-P1747
    Pneumadin, rat

    PNM

    		 Vasopressin Receptor Metabolic Disease
    Pneumadin, rat (PNM) is a decapeptide, which possess a potent stimulating effect on arginine-vasopressin (AVP) release. Pneumadin, rat (PNM) exerts a marked antidiuretic effect in animals with functional AVP system .
    Pneumadin, rat
  • HY-P4320
    Cys-Arg-Gly-Asp-Phe-Pro-Ala-Ser-Ser-Cys (Disulfide bridge: Cys1-Cys10)

    		Integrin Cancer
    Cys-Arg-Gly-Asp-Phe-Pro-Ala-Ser-Ser-Cys (Disulfide bridge: Cys1-Cys10), a decapeptide containing a cyclic RGD active sequence, is an Integrin αIIbβ3 antagonist that inhibits platelet and Adhesion of proMMP-13 .
    Cys-Arg-Gly-Asp-Phe-Pro-Ala-Ser-Ser-Cys (Disulfide bridge: Cys1-Cys10)
  • HY-P11185
    Hsp90β decapeptide

    		HSP Cancer
    Hsp90β decapeptide is a C-terminal peptide of Hsp90β, which contains conserved TPR-domain MEEVD. Hsp90β decapeptide is able to bind tightly the Tah1 protein with a Kd of 1.0 μM .
    Hsp90β decapeptide
  • HY-P2635
    RGDSPASSKP

    		Integrin Cancer
    RGDSPASSKP is a RGDS-containing fibronectin decapeptide .
    RGDSPASSKP
  • HY-P4759
    (D-His2)-Goserelin

    		GnRH Receptor Others
    (D-His2)-Goserelin is a derivative of Goserelin, a decapeptide analog of gonadotropin-releasing hormone (GnRH/LHRH) .
    (D-His2)-Goserelin
  • HY-103289
    MEN 11270

    		Bradykinin Receptor Metabolic Disease Inflammation/Immunology
    MEN 11270, a cyclic decapeptide, is a B2 kinin receptor antagonist. MEN 11270 bound with high-affinity to the B2 kinin receptor constitutively expressed by WI38 human fibroblasts, inhibiting 3H-bradykinin (BK) with a pKi value of 10.3 .
    MEN 11270
  • HY-13673S
    Goserelin-d10

    ICI 118630-d10

    		 Isotope-Labeled Compounds Endocrinology Cancer
    Goserelin-d10 (ICI 118630-d10) is deuterium labeled Goserelin. Goserelin (ICI 118630), a decapeptide analogue of gonadotropin-releasing hormone (GnRH/LHRH), functions as a GnRH agonist. Goserelin can be used for the research of breast cancer, epithelial ovarian cancer and prostate cancer .
    Goserelin-d10
  • HY-172484
    DSPE-PEG1000-LTLRWVGLMS

    		Liposome Cancer
    DSPE-PEG1000-LTLRWVGLMS is a PEG compound which composed of DSPE and a decapeptide (LTLRWVGLMS). The chondroitin sulfate proteoglygan NG2 is a receptor for LTLRWVGLMS. LLRWVGLMS shows the homing of pericytes associated with tumor blood vessels. DSPE-PEG1000-LTLRWVGLMS can be used for drug delivery .
    DSPE-PEG1000-LTLRWVGLMS
  • HY-13673S1
    Goserelin-d7

    ICI 118630-d7

    		 Isotope-Labeled Compounds GnRH Receptor Apoptosis Endocrinology Cancer
    Goserelin-d7 (ICI 118630-d7) is deuterium labeled Goserelin. Goserelin (ICI 118630), a decapeptide analogue of gonadotropin-releasing hormone (GnRH/LHRH), functions as a GnRH agonist. Goserelin can be used for the research of breast cancer, epithelial ovarian cancer and prostate cancer .
    Goserelin-d7
  • HY-172485
    DSPE-PEG2000-LTLRWVGLMS

    		Liposome Cancer
    DSPE-PEG2000-LTLRWVGLMS is a PEG compound which composed of DSPE and a decapeptide (LTLRWVGLMS). The chondroitin sulfate proteoglygan NG2 is a receptor for LTLRWVGLMS. LLRWVGLMS shows the homing of pericytes associated with tumor blood vessels. DSPE-PEG2000-LTLRWVGLMS can be used for drug delivery .
    DSPE-PEG2000-LTLRWVGLMS
  • HY-N14354
    Ferrocin B

    		Antibiotic Bacterial Infection
    Ferrocin B is an iron-containing cyclic decapeptide antibiotic found in the bacterium Pseudomonas fluorescens YK-310, exhibiting strong antibacterial activity primarily against Gram-negative bacteria, with particularly potent inhibitory effects on Pseudomonas aeruginosa. In a mouse infection model, Ferrocin B shows a half effective dose (ED50) of 0.593 mg/kg against P. aeruginosa. Ferrocin B holds potential for research in the field of anti-infective therapies .
    Ferrocin B
  • HY-P11383
    AIM2-derived decapeptide

    		AIM2 MHC Cancer
    AIM2-derived decapeptide is an AIM2-derived decapeptide and HLA-A1-restricted T-cell epitope. AIM2-derived decapeptide can be used in the research of melanoma .
    AIM2-derived decapeptide
  • HY-172485A
    DSPE-PEG3400-LTLRWVGLMS

    		Liposome Cancer
    DSPE-PEG3400-LTLRWVGLMS is a PEG compound which composed of DSPE and a decapeptide (LTLRWVGLMS). The chondroitin sulfate proteoglygan NG2 is a receptor for LTLRWVGLMS. LLRWVGLMS shows the homing of pericytes associated with tumor blood vessels. DSPE-PEG3400-LTLRWVGLMS can be used for drug delivery .
    DSPE-PEG3400-LTLRWVGLMS
  • HY-172486
    DSPE-PEG5000-LTLRWVGLMS

    		Liposome Cancer
    DSPE-PEG5000-LTLRWVGLMS is a PEG compound which composed of DSPE and a decapeptide (LTLRWVGLMS). The chondroitin sulfate proteoglygan NG2 is a receptor for LTLRWVGLMS. LLRWVGLMS shows the homing of pericytes associated with tumor blood vessels. DSPE-PEG5000-LTLRWVGLMS can be used for drug delivery .
    DSPE-PEG5000-LTLRWVGLMS
  • HY-P11614
    LCA-H10

    		Liposome Cancer
    LCA-H10 is a lithocholic acid-histidine decapeptide conjugate, a biocompatible lipid nanoparticle (LNP) additive that reduces ionizable lipid proportions, functions as an endosomal escape inducer, and enhances siRNA encapsulation. LCA-H10 increases hepatic accumulation of LNPs in mice after intravenous injection when incorporated into LiLNP-LH and reduces proinflammatory cytokines (IL-6, TNF, IL-1β) in mouse serum. LCA-H10 can be used for the research of prostate cancer .
    LCA-H10

Inquiry Online

Your information is safe with us. * Required Fields.

Salutation

  

Country or Region *

Applicant Name *

 

Organization Name *

Department *

     

Email Address *

 

Product Name *

Cat. No.

  

Requested quantity *

Phone Number *

     

Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent: